- Koninklijke Philips NV PHG reported second-quarter FY21 sales growth of 6% year-on-year to €4.23 billion.
- Comparable sales grew 9% Y/Y, representing double-digit growth in the Personal Health businesses and Diagnosis & Treatment businesses, partly offset by a double-digit decline in the Connected Care businesses.
- The comparable order intake decreased by 15%, with double-digit growth in the Diagnosis & Treatment businesses, which was more than offset by a double-digit decline in the Connected Care businesses.
- The Diagnosis & Treatment businesses posted 16% comparable sales growth Y/Y with double-digit growth in all businesses. The comparable order intake rose 29% Y/Y, with strong double-digit growth in Image-Guided Therapy, Ultrasound, and Diagnostic Imaging. The adjusted EBITDA for the segment was 13.2%.
- The comparable sales in the Connected Care businesses declined 16% Y/Y. The adjusted EBITDA was 11.3%.
- The Personal Health businesses recorded a comparable sales growth of 33% Y/Y, driven by double-digit growth across every business. The adjusted EBITDA was 17%.
- The consolidated adjusted EBITA expanded 280 basis points to 12.6%, driven by sales growth and productivity measures.
- It recorded an EPS of €0.16.
- The adjusted EBITDA expanded 210 basis points to 18%.
- Philips generated €332 million in operating cash flow.
- It held €1 billion in cash and equivalents.
- The company launched a €1.5 billion share buyback program.
- Outlook: Philips’ FY21financial outlook remains within its guided range for low-to-mid-single-digit comparable sales growth. Adjusted EBITA margin improvement of 60 basis points, versus prior outlook for improvement of 60-80 basis points.
- Price action: PHG shares traded lower by 4.13% at $45.96 in the premarket session on the last check Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
